StocksRunner logo
 
  Overview  
 
  Chart  
 
  Earnings  
 
  Sentiment  
 
  News  
 
  Updates  
 
 
 
TG Therapeutics
13.32
-0.89%
 

TGTX

 

TG Therapeutics

$ 13.32

 
-$0.12 | -0.89%
 
 
Open
$ 13.36
 
 
MKT CAP
$ 2.02B
 
High
$ 13.56
 
 
VOL
$ 2.39M
 
Low
$ 13.19
 
 
AVG VOL
$ 4.82M
 
 
 

TGTX Stock Analysis

  Login to display TG Therapeutics (TGTX) recommendation from the last 90 days from financial news and social media.
 
 

TGTX Total Score

 

Chart

 
 

17.22

12.79

6.94

15.32

 
 
1month
3month
6month
1year
 
Total Return
TGTX
vs.
S&P500
 

 
1-week Return
-7.50%
 
+1.17%
 
 
5-week Return
-12.02%
 
+6.44%
 
 
10-week Return
-12.43%
 
+10.09%
 
 
 
 

Strengths

TGTX Rewards

 Upgraded on attractively valued

TGTX Rewards

 Trading below its fair value

 
 

TGTX Risk Level

This Indicator assigning risk levels based on factors such as volatility, sector strength, trading volume, investor confidence and market outlook.

 
TGTX Risk Level
LOW
HIGH

Risk Volatility

 

TGTX has Medium Risk Level

Click here to check what is your level of risk

 

TGTX Analysts Opinion

The company overall standing based on key factors, offering insights into analysts perspectives and market expectations. Hover over the category for more information

 
 

Earnings

×
 

Earnings

4.00
 

TGTX Earnings Sentiment

 Above analyst estimates

 
 

Rating

×
 

Rating

5.00
 

TGTX Rating Sentiment

 Upgraded on attractively valued

 

Momentum

×
 

Momentum

4.00
 

TGTX Momentum Analysis

 Has been gaining momentum

 

Activity

×
 

Activity

4.00
 
 

Future

×
 

Future

4.50
 

TGTX Future Sentiment

 Trading below its fair value

 
 

TGTX Analysts Opinion

TGTX Analysts opinion is positive and also has improved from the past 3 months

 

TGTX Street Consensus

Analysts perspectives on the stock desirability, trend direction, and growth potential.

 
100%
Buy
Opinion
Trend
Score
Potential
Score
 
 
100%
100%
100%
 
On Track
On Track
On Track
 

TGTX Street Opinion 

TGTX Street view is extremely ish and have positive views on the near-term outlook

 

TGTX Performance Sentiment

Sentiments overview associated with the company events and the stock performance.
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 
Positive vs Negative
Contrasts the positive and negative sentiments surrounding the company performance.
 
100%
0%
Positive
Negative
11 out of 11
events present
0 out of 11
events present
 
 
Highlights
Last Modify
Price
% Change

 
Buy Rating
2 Month Ago
17.22
-3.10%
 
Agreements
2 Month Ago
21.01
-1.36%
 
Investors Activity
2 Month Ago
19.65
+9.05%
 
 

TGTX Latest News Feed









 
 
 
joker
 
 
 
StocksRunner

Explore our TGTX Stock insights

  • In-Depth Market Analysis and Trends
  • Expert Insights on Market Dynamics
  • Tailored FDX Stock Strategies
  • Effective Risk Management
 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss
 

Receive our TGTX Daily Alerts

Access the exclusive insights that over 10,000+ subscribers value. Stay ahead in the stock market! Submit your email for daily alerts.

 
Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

 
Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

 
Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

 
About StocksRunner

Log In

Sign Up

Contact Us

Terms of use

Privacy Policy

 
 

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
StocksRunner logo

StocksRunner

Get the pulse of the market

 
StocksRunner
 
 

Most Trending

 
 

-2.76%

 
 
 
 
 
 
 
 
 

Stock Insights

 
 
 
 

Strengths

 

TGTX Rewards

 Upgraded on attractively valued

TGTX Rewards

 Trading below its fair value

 
 
 

TGTX Risk Level

 
 
 

The Indicator assigning risk levels based on factors such as volatility, sector strength, trading volume, investor confidence and market outlook.

 
 
TGTX Risk Level
LOW
HIGH

Risk Volatility

 

TGTX has Medium Risk Level. Click here to check what is your level of risk

 
 
 
 

Stock Analysis

 
 
 
 

TGTX

 

TG Therapeutics

$ 13.32

 
-$0.12 | -0.89%
 
 
  Overview  
 
  Chart  
 
  Earnings  
 
  Sentiment  
 
  News  
 
  Updates  
 

 
joker
 
 
 
Open
$ 13.36
 
 
MKT CAP
$ 2.02B
 
High
$ 13.56
 
 
VOL
$ 2.39M
 
Low
$ 13.19
 
 
AVG VOL
$ 4.82M
 
 
 

TGTX Analysis

  Sign in to view TG Therapeutics (TGTX) recommendation from the last 90 days from financial news and social media.
 
 

Chart

 
 

17.22

12.79

6.94

15.32

 
 
1month
3month
6month
1year
 
Total Return
TGTX
vs.
S&P500
 

 
1-week Return
-7.50%
 
+1.17%
 
 
5-week Return
-12.02%
 
+6.44%
 
 
10-week Return
-12.43%
 
+10.09%
 
 
 

TGTX Analysts Opinion

Overall standing by considering key factors, reflecting analysts perspectives and market expectations. Hover over the category for more information

 
 

Earnings

×
 

Earnings

4.00
 

TGTX Earnings Sentiment

 Above analyst estimates

 
 

Rating

×
 

Rating

5.00
 

TGTX Rating Sentiment

 Upgraded on attractively valued

 

Momentum

×
 

Momentum

4.00
 

TGTX Momentum Sentiment

 Has been gaining momentum

 

Activity

×
 

Activity

4.00
 
 

Future

×
 

Future

4.50
 

TGTX Future Sentiment

 Trading below its fair value

 
 

TGTX Analysts Opinion

TGTX Analysts opinion is positive and also has improved from the past 3 months

 

TGTX Street Consensus

Analysts perspectives on the stock desirability, trend direction, and growth potential.

 
100%
Buy
Opinion
Trend
Score
Potential
Score
 
 
100%
100%
100%
 
On Track
On Track
On Track
 

TGTX Street Opinion 

TGTX Street view is extremely ish and have positive views on the near-term outlook

 
TGTX Performance Sentiment
Sentiments overview associated with the company events and the stock performance.
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 
Positive vs Negative
Contrasts the positive and negative sentiments surrounding the company performance.
 
100%
0%
Positive
Negative
11 out of 11
events present
0 out of 11
events present
 

 
Highlights
Last Modify
Price
% Change

 
Buy Rating
2 Month Ago
17.22
-3.10%
 
Agreements
2 Month Ago
21.01
-1.36%
 
Investors Activity
2 Month Ago
19.65
+9.05%
 
 
TGTX Latest News Feed

TG Therapeutics (TGTX) Price Target Increased by 5.80% to 30.89. The average one-year price target for TG Therapeutics (NasdaqCM:TGTX) has been revised to 30.89 / share. This is an increase of 5.80% from the prior estimate of 29.20 dated Januar

Sat Feb 24, 2024

Potential

tg therapeutics: inferred expectations point to undervalued shares.

Thu Feb 8, 2024

Potential

looking into tg therapeuticss recent short interest. ) short percent of float has fallen 12.86% since its last report. the company recently reported that it has

Fri Jan 19, 2024

Activity

hc wainwright & co. maintains buy rating for tg therapeutics: heres what you need to know. hc wainwright &. co. has decided to maintain its buy rating of tg therapeutics (nasdaq:) and raise its price target from $41.00 to $45.00. shares of tg therapeu

Thu Jan 11, 2024

Momentum
Rating

tg therapeutics acquires worldwide license agreement for precisions cell therapy program. (rttnews) - tg therapeutics inc. (tgtx) announced on tuesday that it has acquired a worldwide license to precision biosciences inc.s azercabtagene zapreleu

Tue Jan 9, 2024

Activity

precision biosciences in deal with tg therapeutics on cell therapy azer-cel. (rttnews) - precision biosciences inc. (dtil) tuesday announced a deal with tg therapeutics inc. granting exclusive license to develop azercabtagene zapreleucel (azer-c

Tue Jan 9, 2024

Activity

tg therapeutics spikes. to present at j. p. morgan conference.

Fri Jan 5, 2024

Activity

 
 
 
 
 

Score Tracker

 
 
 
Based on 11 events in the last 90 days from financial news and social media. Last updated Feb 23, 2024 13:28 Wall St. time
 
 

TGTX Total Score

 
 
 
 
 
 
 
StocksRunner

Discover TGTX Stock analysis and effective trading strategies with StocksRunner. Gain valuable insights into stock performance, market trends, and the future potential of TGTX. We're here to help you make informed investment decisions today.

 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss

 

Receive our TGTX Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

 
Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

TGTX Stock trends

TGTX Stock performance

TGTX Stock analysis

TGTX investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner ideas

Financial Reports

 
 

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
 
Post ×
 
0/666
joker